ロード中...
Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?
BACKGROUND: The perioperative use of antithrombotic therapy is associated with increased bleeding risk after cardiac implantable electronic device (CIED) implantation. Topical application of tranexamic acid (TXA) is effective in reducing bleeding complications after various surgical operations. Howe...
保存先:
| 出版年: | BMC Cardiovasc Disord |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4841978/ https://ncbi.nlm.nih.gov/pubmed/27105588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-016-0251-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|